Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

To understand the global market potential, growth, and scope, the market is segmented based on product type (drug-eluting ...

TCT discussant Joanna Wykrzykowska, MD, PhD, of University Medical Center Groningen in the Netherlands, said she was "very ...

There's been little doctors can do to help patients in this situation, but a newly developed 'hourglass' stent may be a novel ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...

For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent ...

Hello Health Rounds Readers! Today we have three studies presented at medical meetings, including one testing a device that ...

It is an advanced dual-drug polymer-free coated stent (DDCS). A significant development in drug-eluting stent technology, ...

One of the presenters of BBC's Springwatch last year announced they'd had a heart attack after having a stent fitted, however ...

Un cœur qui bat plus fort. Le 10 octobre, le centre hospitalier de Valenciennes a été le second hôpital des Hauts-de-France a réalisé l’implantation d’un stent résorbable, sur un patient de 44 ans.

Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced late-breaking data demonstrating significant b ...